Latest Europe News

Stakk Limited is set to become a global powerhouse in AI-driven Digital Trust infrastructure following its US$63 million acquisition of ParaScript, a leader in AI-powered document intelligence and fraud detection. The deal significantly boosts Stakk's scale, technology, and recurring revenue base, underpinning a robust growth trajectory.

ADX Energy’s Sicily Channel biogenic gas play gains validation from an independent technical review, reinforcing its prospective resource estimates and exploration strategy.

First Graphene has signed an MOU with Sixth Element to distribute its PureGRAPH® CEM additive across China, with potential for local manufacturing via a joint venture once sales milestones are met.

European Lithium and Critical Metals Corp. have amended their merger agreement, introducing a sale facility option for small shareholders and switching to direct share issuance, aiming for scheme implementation in October 2026.

EMC Gold appoints Agne Ahlenius as CEO, reinforcing its strategic pivot to Spain with leadership focused on advancing the Salave Gold Project’s permitting and stakeholder engagement.

Germany’s Hesse State Office has issued new GMP guidance that questions the viability of fragmented medicinal cannabis supply chains, reinforcing ECS Botanics’ integrated manufacturing approach and potentially tightening market supply.

Osmond Resources is advancing its Orión EU Critical Minerals Project with imminent assay results, upcoming resource estimates, and a secondary listing on the Madrid Stock Exchange, aiming to become the EU's first producer of rare earth-bearing minerals.

Orthocell has secured a strategic foothold in Thailand's $84 million nerve repair sector by appointing MediTime as exclusive Remplir distributor, leveraging established clinical networks to accelerate market penetration.

OncoSil Medical has submitted its Humanitarian Device Exemption application to the FDA for its OncoSil™ device targeting distal cholangiocarcinoma, entering the final review phase with a decision expected within 45 days.

Talga Group has begun commercial deliveries of its Talnode®-C battery anode to Nyobolt, marking a key revenue milestone and advancing its European supply ambitions. The 3,000-tonne offtake deal sets the stage for Talga's planned commercial-scale anode plant, with further customer negotiations underway.

Cyclopharm Limited delivered a record $17.1 million in revenue for 1H FY26, driven by a 73% surge in US Technegas® sales. However, delays in clinical guideline publication have pushed the short-term US installation target beyond 2026, while medium-term ambitions remain intact.

Telix Pharmaceuticals has gained FDA alignment to advance Part 2 of its ProstACT Global Phase 3 trial for TLX591-Tx in metastatic castration-resistant prostate cancer, setting the stage for U.S. enrolment pending regulatory approval.